GREEN SYNTHESIS, CHARACTERIZATION, AND ANTHELMINTHIC ACTIVITY OF NEWER QUINOLINE DERIVATIVES CONTAINING ACRIDINE MOIETY
Â Objectives: Synthesis of newer 3,4,6,7-tetrahydro-3,3,6,6-tetramethyl-9-(2-chloro-6-substituted-quinolin-3-yl)-acridine-1,8(2H,5H,9H,10H)-diones were synthesized by reacting 5,5-dimethylcyclohexane-1,3-dione with substituted 2-chloro-quinoline-3-carbaldehyde in presence of ammonium acetate.
Methods: Synthesis was carried out by microwave irradiation method and the synthesized compounds have been characterized using elemental analysis, FT-IR, 1H NMR, and 13C NMR spectroscopy and further supported by mass spectroscopy. Purity of all the compounds has been checked on thin layer chromatographic plate and high-performance liquid chromatography technique. All the synthesized compounds were tested for antibacterial and anthelminthic activities.
Results: The results were revealed that the compounds AQ-4 and AQ-5 have showed good activity against both Gram-positive and Gram-negative bacteria. Compounds AQ-4 and AQ-5 showed moderate activity against all the organisms. However, all the derivatives have shown less antibacterial activity when compared to the standard drug amikacin. The compounds AQ-3 and AQ-5 showed good anthelminthic activity and compounds AQ-9 and AQ-10 showed moderate anthelminthic activity. However, all the compounds have shown less anthelmintic activity when compared to the standard drug albendazole.
Conclusion: The study reveals that compounds containing quinoline derivatives with acridine moiety shown the antibacterial activity against the pathogens Bacillus subtilis, Bacillus cereus, Staphylococcus epidermidis, Salmonella typhi, Pseudomonas aeruginosa and Klebsiella pneumoniae. These derivatives also possess the good anthelmintic activity. The above green synthesis technique could be a right solution for industrial applications in the future and therapeutic needs.
2. Ozyanik M, Demirci S, Bektas H, DemirbaÅŸ N, DermirbaÅŸ A, Karaoglu SA. Preparation and antimicrobial activity evaluation of some quinoline derivatives containing an azole nucleus. Turk J Chem 2012;36:233-46.
3. Maddela S, Ajitha M, Venugopal M, Maddela R. Design and synthesis of novel quinoline 3-carbohydrazone derivatives for their antimicrobial and antioxidant activity. Int J Pharm Pharm Sci 2014;6(6):254-8.
4. Radini IA, Elsheikh TM, El-Telbani EM, Khidre RE. New potential antimalarial agents: Design, synthesis and biological evaluation of some novel quinoline derivatives as antimalarial agents. Molecules 2016;21(7). pii: E909.
5. Kumar S, Goel N, Afzal O, Ali MR, Bawa S. In-vitro antibacterial/ antifungal screening of 2-chloroquinoline scaffold derivatives. J Antibiot Res 2015;1(1):101.
6. Asnani AJ, Sahare S. Synthesis and pharmacological studies of some novel benzoquinoline derivatives. Asian J Pharm Clin Res 2013;6 Suppl 2:303-8.
7. Wen X, Wang SB, Liu DC, Gong GH, Quan ZS. Synthesis and evaluation of the anti-inflammatory activity of quinoline derivatives. Med Chem Res 2015;24(6):2591.
8. Ramjith US, Radhika G, Muhammed Shakeel KV, Nabeel CK, Cherian A. Conventional and microwave assisted synthesis of novel quinoline derivatives and their antimicrobial and antioxidant potential. Int J Pharm Pharm Sci 2013;5 Suppl 4:521-4.
9. Fakhfakh MA, Fournet A, Prina E, Mouscadet JF, Franck X, Hocquemiller R, et al. Synthesis and biological evaluation of substituted quinolines: Potential treatment of protozoal and retroviral co-infections. Bioorg Med Chem 2003;11(23):5013-23.
10. Ghosh J, Swarup V, Saxena A, Das S, Hazra A, Paira P, et al. Therapeutic effect of a novel anilidoquinoline derivative, 2-(2-methyl-quinoline- 4ylamino)-N-(2-chlorophenyl)-acetamide, in Japanese encephalitis: Correlation with in vitro neuroprotection. Int J Antimicrob Agents 2008;32(4):349-54.
11. Rossiter S, PÃ©ron JM, Whitfield PJ, Jones K. Synthesis and anthelmintic properties of arylquinolines with activity against drug-resistant nematodes. Bioorg Med Chem Lett 2005;15(21):4806-8.
12. Muruganantham N, Sivakumar R, Anbalagan N, Gunasekaran V, Leonard JT. Synthesis, anticonvulsant and antihypertensive activities of 8-substituted quinoline derivatives. Biol Pharm Bull 2004;27(10):1683-7.
13. Rano TA, Sieber-McMaster E, Pelton PD, Yang M, Demarest KT, Kuo GH. Design and synthesis of potent inhibitors of cholesteryl ester transfer protein (CETP) exploiting a 1,2,3,4-tetrahydroquinoline platform. Bioorg Med Chem Lett 2009;19(9):2456-60.
14. Smith PW, Wyman PA, Lovell P, Goodacre C, Serafinowska HT, Vong A, et al. New quinoline NK3 receptor antagonists with CNS activity. Bioorg Med Chem Lett 2009;19(3):837-40.
15. Edmont D, Rocher R, Plisson C, Chenault J. Synthesis and evaluation of quinoline carboxyguanidines as antidiabetic agents. Bioorg Med Chem Lett 2000;10(16):1831-4.
16. Mouscadet JF, DesmaÃ«le D. Chemistry and structure-activity relationship of the styrylquinoline-type HIV integrase inhibitors. Molecules 2010;15(5):3048-78.